96 filings
Page 2 of 5
8-K
ejd86jq3xce74nt9 qgh
2 Mar 23
Regulation FD Disclosure
4:06pm
8-K
ktuxvsz1cf9phvxmikp
10 Feb 23
AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Financial Guidance
4:09pm
8-K
ughe3i 1r6yi1mbt6
19 Jan 23
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
7:43pm
8-K
pmoyv
20 Dec 22
Other Events
4:06pm
8-K
v3wwmrdtkgsc
14 Dec 22
Mr. Lou Panaccio, Chairman of the Board of AVITA Medical, Inc. Call To Order
4:06pm
8-K
3vu xoysi6oxhjxltxem
14 Nov 22
AVITA Medical Reports Third Quarter 2022 Financial Results
6:18am
8-K
e6svnn
9 Nov 22
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
4:54pm
8-K
lc8p9
30 Sep 22
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
8:54am
8-K
l5gqng
22 Sep 22
Regulation FD Disclosure
4:06pm
8-K
zvvk72q1v 5weas
13 Sep 22
AVITA Medical Achieves Positive Topline Pivotal Trial Results for Treatment of Stable Vitiligo Using the RECELL® System
9:20am
8-K
96ig5
2 Sep 22
RECELL® System Insurance Coverage Begins in Japan for Treatment of Acute Burns
9:03am
8-K
zm3wl
30 Aug 22
Regulation FD Disclosure
11:30am
8-K
b8mbnf
12 Aug 22
AVITA Medical Reports Second Quarter 2022 Financial Results
1:21pm
8-K
v18tcp007bl 7dw
22 Jul 22
Other Events
4:01pm
8-K
g3pi28m8 3xg45kjt1
17 May 22
AVITA Medical Reports First Quarter 2022 Financial Results
4:03pm
8-K
ygxjhcd8wd5r erqd
10 May 22
RECELL® System to be Highlighted at Upcoming Music City SCALE
4:02pm
8-K
4wcy8pl3
29 Apr 22
AVITA Medical to Announce First Quarter 2022 Financial Results
12:11pm
8-K
hcifqq410xw90pot
21 Apr 22
Avita Medical, Inc. Announces Resignation of Louis Drapeau from Board of Directors
4:40pm
8-K
ipsm1
5 Apr 22
RECELL® System Data to be Presented at the American Burn Association Annual Meeting
4:02pm
8-K
pjf029i
24 Mar 22
AVITA Medical Announces Modification of BARDA Contract to Advance Development of RECELL® System in Soft Tissue Reconstruction
4:06pm